Top Section/Ad
Top Section/Ad
Most recent
M&A could be much needed shot in the arm but dollars expected to dominate
Deal includes $1bn 3.75 year term loan
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month
US drug company Eli Lilly jolted the dollar market awake on Wednesday with an eight-part jumbo trade to fund two recent acquisitions
More articles/Ad
More articles/Ad
More articles
-
It could take years to develop a gene therapy to slow aging, but much less for big pharma to scoop up Genflow Biosciences -
PRA to return to risk-weighted asset-based calculation for Pillar 2A
-
The pandemic has helped the Swiss online pharmacy to boost its business
-
Emerging markets reliant upon tourism find relief
-
German medical company is working towards reinclusion in the SDax
-
Emerging markets have come under pressure this week, but some could fare worse than others
